Literature DB >> 3435693

Determinants of free theophylline clearance in asthma.

P E Williams1, Y A Alwazir, M Littley, D C Buss, R John, I A Campbell, P A Routledge, J H Lazarus.   

Abstract

1. The free and total plasma and saliva concentrations of theophylline were measured during a dosing interval at steady state in nineteen asthmatic subjects receiving a once-daily theophylline preparation (Riker TCR-1). 2. Saliva theophylline clearance (mean +/- s.d. 5.8 +/- 2.1l h-1) was closely related to total plasma theophylline clearance (mean 3.6 +/- 1.2l h-1) (r = 0.958, n = 19, P less than 0.001). 3. Saliva theophylline clearance was closely related (r = 0.967, n = 19, P less than 0.001) and numerically very similar to the free plasma theophylline clearance (mean 5.8 +/- 1.9l h-1) (mean difference = 0.06 +/- 0.12 s.e. mean). 4. Free plasma theophylline clearance was significantly, although weakly, related to body weight and to the plasma free thyroxine concentration which together accounted for over 40 per cent of the variability in free clearance. 5. Theophylline administered for 2 weeks did not affect plasma free thyroxine (FT4) free tri-iodothyronine (FT3) or reverse tri-iodothyronine (rT3) concentrations compared with placebo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435693      PMCID: PMC1386338          DOI: 10.1111/j.1365-2125.1987.tb03225.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.

Authors:  P E Williams; Y A Alwazir; P A Routledge; I A Campbell
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

2.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

3.  Theophylline analysis by reversed-phase high-pressure liquid chromatography: elimination of interferences.

Authors:  J R Miksic; B Hodes
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

4.  Influence of thyroid function on theophylline kinetics.

Authors:  S Vozeh; M Otten; J J Staub; F Follath
Journal:  Clin Pharmacol Ther       Date:  1984-11       Impact factor: 6.875

5.  Free and total plasma theophylline concentrations in chronic airflow obstruction.

Authors:  P Ebden; D Leopold; A P Smith; D Buss; P A Routledge
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

6.  Theophylline kinetics in relation to age: the importance of smoking.

Authors:  B Cusack; J G Kelly; J Lavan; J Noel; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

7.  Pharmacokinetics of theophylline in young and elderly subjects.

Authors:  R A Blouin; W G Erwin; T S Foster; S Scott
Journal:  Gerontology       Date:  1982       Impact factor: 5.140

  7 in total
  1 in total

1.  The effect of theophylline on thyrotoxic tremor.

Authors:  D C Buss; D I Phillips; M D Littley; R W Marshall; P A Routledge; J H Lazarus
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.